Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chanal

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|October 1, 1994
Sequences of CAZ-3 and CTX-2 extended-spectrum beta-lactamase genesC Chanal, D Sirot, H Malaure, et al.
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Clinical relevance of Proteus mirabilis in hospital patients: a two year surveyC de Champs, R Bonnet, D Sirot, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
Identification of CTX-2, a novel cefotaximase from a Salmonella mbandaka isolateM C Poupart, C Chanal, D Sirot, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1996
Survey of prevalence of extended spectrum beta-lactamases among enterobacteriaceaeC Chanal, D Sirot, J P Romaszko, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study GroupC De Champs, D Sirot, C Chanal, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1989
Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniaeD Sirot, C Chanal, R Labia, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamasesC Chanal, D Sirot, M Chanal, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9C Aumeran, C Chanal, R Labia, et al.
Pathologie-Biologie|May 1, 1991
[In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve]C J Soussy, M D Kitzis, C Chanal, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5)F Robin, J Delmas, C Chanal, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|October 1, 1994
Sequences of CAZ-3 and CTX-2 extended-spectrum beta-lactamase genesC Chanal, D Sirot, H Malaure, et al.
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Clinical relevance of Proteus mirabilis in hospital patients: a two year surveyC de Champs, R Bonnet, D Sirot, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
Identification of CTX-2, a novel cefotaximase from a Salmonella mbandaka isolateM C Poupart, C Chanal, D Sirot, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1996
Survey of prevalence of extended spectrum beta-lactamases among enterobacteriaceaeC Chanal, D Sirot, J P Romaszko, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study GroupC De Champs, D Sirot, C Chanal, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1989
Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniaeD Sirot, C Chanal, R Labia, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamasesC Chanal, D Sirot, M Chanal, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9C Aumeran, C Chanal, R Labia, et al.
Pathologie-Biologie|May 1, 1991
[In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve]C J Soussy, M D Kitzis, C Chanal, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5)F Robin, J Delmas, C Chanal, et al.
Pageof 6